{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:54Z","timestamp":1786123434508,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1213\/ane.0b013e3181ae94c7","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:16:20Z","timestamp":1253070980000},"page":"1273-1277","source":"Crossref","is-referenced-by-count":2,"title":["Novel Variants Near the Central Domain of RYR1 in Two Malignant Hyperthermia-Susceptible Families from Taiwan"],"prefix":"10.1213","volume":"109","author":[{"given":"Po-Liang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chih","family":"Hsiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ji","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-41-20210902","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"R2-41-20210902","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000542-199803000-00006","article-title":"The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.","volume":"88","author":"Allen","year":"1998","journal-title":"Anesthesiology"},{"key":"R3-41-20210902","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000542-200201000-00036","article-title":"Testing for malignant hyperthermia.","volume":"96","author":"Rosenberg","year":"2002","journal-title":"Anesthesiology"},{"key":"R4-41-20210902","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"R5-41-20210902","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00000542-200405000-00008","article-title":"Molecular genetic testing for malignant hyperthermia susceptibility.","volume":"100","author":"Girard","year":"2004","journal-title":"Anesthesiology"},{"key":"R6-41-20210902","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1001\/jama.293.23.2918","article-title":"Malignant hyperthermia: update on susceptibility testing.","volume":"293","author":"Litman","year":"2005","journal-title":"JAMA"},{"key":"R7-41-20210902","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R8-41-20210902","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000542-200410000-00005","article-title":"Malignant hyperthermia in North America: genetic screening of the three hot spots in the type I ryanodine receptor gene.","volume":"101","author":"Sei","year":"2004","journal-title":"Anesthesiology"},{"key":"R9-41-20210902","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"R10-41-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility.","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R11-41-20210902","doi-asserted-by":"crossref","first-page":"48077","DOI":"10.1074\/jbc.M107134200","article-title":"B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.","volume":"276","author":"Girard","year":"2001","journal-title":"J Biol Chem"},{"key":"R12-41-20210902","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000542-200211000-00005","article-title":"Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.","volume":"97","author":"Sei","year":"2002","journal-title":"Anesthesiology"},{"key":"R13-41-20210902","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00000542-200606000-00014","article-title":"Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia.","volume":"104","author":"McKinney","year":"2006","journal-title":"Anesthesiology"},{"key":"R14-41-20210902","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj3190421","article-title":"Calmodulin sensitivity of the sarcoplasmic reticulum ryanodine receptor from normal and malignant-hyperthermia-susceptible muscle.","volume":"319","author":"O'Driscoll","year":"1996","journal-title":"Biochem J"},{"key":"R15-41-20210902","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia.","volume":"23","author":"Jurkat-Rott","year":"2000","journal-title":"Muscle Nerve"},{"key":"R16-41-20210902","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"R17-41-20210902","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1213\/01.ANE.0000180214.74580.39","article-title":"Denaturing high performance liquid chromatography screening of ryanodine receptor type 1 gene in patients with malignant hyperthermia in Taiwan and identification of a novel mutation (Y522C).","volume":"101","author":"Yeh","year":"2005","journal-title":"Anesth Analg"},{"key":"R18-41-20210902","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<45::AID-HUMU7>3.0.CO;2-K","article-title":"Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia.","volume":"11","author":"Manning","year":"1998","journal-title":"Hum Mutat"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e3181ae94c7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:38Z","timestamp":1786112858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200910000-00041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181ae94c7","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}